Intravitreal Anti-Vascular Endothelial Growth Factor Injections for Macular Edema Associated With Central Retinal Vein Occlusion in Patients Age 40 Years or Younger-Reference-Cited by-同舟云学术

Intravitreal Anti-Vascular Endothelial Growth Factor Injections for Macular Edema Associated With Central Retinal Vein Occlusion in Patients Age 40 Years or Younger

Published:2019-04 Issue:4 Volume:50 Page:
ISSN:2325-8160
Container-title:Ophthalmic Surgery, Lasers and Imaging Retina
language:en
Short-container-title:Ophthalmic Surg Lasers Imaging Retina

Author:

Gao Xinxiao,Obeid Anthony,Aderman Christopher M.,Ali Ferhina S.,Vander James F.,Hsu Jason,Ho Allen C.

Publisher

SLACK, Inc.

Subject

Ophthalmology,Surgery

Reference27 articles.

1. Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion;Braithwaite T;Cochrane Database Syst Rev,2014

2. Natural History of Central Retinal Vein Occlusion: An Evidence-Based Systematic Review

3. Incidence and characteristics of patients with visual impairment due to macular edema secondary to retinal vein occlusion in a representative Canadian cohort;Petrella RJ;J Ophthalmol,2012

4. Intraocular Concentrations of Growth Factors and Cytokines in Retinal Vein Occlusion and the Effect of Therapy with Bevacizumab

5. Vascular Endothelial Growth Factor A in Intraocular Vascular Disease

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expressions of HIF-1α and MiR-210 in aqueous humor of patients with central retinal vein occlusion combined with macular edema;Pakistan Journal of Medical Sciences;2022-04-25

2. Comparative efficacy and safety of antivascular endothelial growth factors for central retinal vein occlusion;Medicine;2021-12-30

3. Age-related differences in presentation and outcomes of anti-VEGF treatment of retinal vein occlusion;Canadian Journal of Ophthalmology;2021-04